Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Baudax Bio Inc develops and commercializes novel products for acute care settings that include product candidate meloxicam to treat osteoarthritis and rheumatoid arthritis. The company is headquartered in Chester, Pennsylvania, the US.
Headquarters
United States of America
Address
490 Lapp Road, Malvern, Pennsylvania, 19355
Website
www.baudaxbio.com
Telephone
1 484 3952470
No of Employees
9
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
BXRXQ (OTC)
Revenue (2022)
$1.3M
17.5%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-197.4%
(2022 vs 2021)
Net Profit Margin (2022)
XYZ
-153.1%
(2022 vs 2021)
* As of and is in US$
Competitor Comparison
| Key Parameters | Baudax Bio Inc | PhaseBio Pharmaceuticals Inc |
|---|---|---|
| Headquarters | United States of America | United States of America |
| City | Malvern | Malvern |
| State/Province | Pennsylvania | Pennsylvania |
| No. of Employees | 9 | 60 |
| Entity Type | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer